Human Pai 1 Recombinant Glycosylated Stable MutantIHUPAI1RGSM500UG
Select this product for Molecular Innovations name, Human PAI-1 (Glycosylated - stable mutant) and product number, GLYCPAI.
Human PAI-1 Recombinant Glycosylated Stable Mutant from Innovative Research has been recombinantly produced in insect cell culture and purified by affinity chromatography. This is a Frozen liquid buffered in 0.05M Sodium Phosphate; 0.1M NaCl; 1mM EDTA; pH 6.6 with a concentration of 2.5 mg/ml and a purity of >95% as determined by SDS-PAGE.
- Species: Human
- Target: PAI-1
- Purification Method: Affinity purified
- Purity: >95% as determined by SDS-PAGE Analysis
- Source: Insect cell culture
- Storage Conditions: -70 C
Glycolyslated human PAI-1 recombinantly produced in insect cells. Molecular weight of 46,000 Da. The stable mutant contains four mutations (K154T, Q319L, M354I and N150H) to confer additional stability to the otherwise labile molecule.
This product can be used as a control in applications like ELISA and Western Blot. It can be used for a wide range of in vitro applications, including affinity purification, blocking, fibrinolysis, hypertension studies, inhibition, plasminogen activation, protein-protein interactions, receptor binding, and more. At Innovative Research, we provide reliable, consistent products that deliver reliable, consistent results.
This material is sold for in-vitro use only for manufacturing and research. This material is not suitable for human or animal use. While we make every effort to ensure the safety of our products, we recommend handling any biological materials with standard precautions as if capable of spreading infectious disease. The statements herin are offered for informational purposes only to be used solely for your consideration, investigation, and verification.
Please be aware the image pictured is for illustrative purposes only, and your product packaging and appearance may vary.
Get in touch with our team! Please include any relevant information (product name, etc)